NCT02799849

Brief Summary

A significant weight gain and obesity are observed for most patients with narcolepsy, mainly at the beginning of the disease and narcolepsy in young children. There is no specific study on the population and the consequences of overweight in the lives of these long-term patients. Narcoleptic patients gain weight significantly at the onset of their illness. It is also known that weight gain is not related to the treatment of narcolepsy. The etiology of obesity in narcoleptic patients is not established. Several assumptions were made (physical activity, leptin diet, metabolism). The reason and the pathophysiology of overweight and obesity in this population therefore remain unclear. In this study, potential change in the total metabolism (24h) for narcoleptic children that could explain their tendency to obesity will be assessed ?

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 20, 2013

Completed
2.4 years until next milestone

First Submitted

Initial submission to the registry

May 3, 2016

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 15, 2016

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2018

Completed
Last Updated

December 19, 2025

Status Verified

December 1, 2025

Enrollment Period

4.7 years

First QC Date

May 3, 2016

Last Update Submit

December 13, 2025

Conditions

Keywords

narcolepsymetabolism

Outcome Measures

Primary Outcomes (1)

  • Determination of the metabolism at home

    Total energy expenditure in kilocalories per minute, including basal metabolic rate (MET) metabolism related to the activity (EEA), and physical activity (PA) measured by accelerometer (Actical) evaluated at home (15 days including scholar and non-scholar days).

    15 days

Secondary Outcomes (22)

  • Determination of the metabolism at hospital

    18 days

  • Basal energy expenditure

    18 days

  • Energy expenditure and diet-induced thermogenesis

    18 days

  • Sympathetic activity

    18 days

  • Food intake

    18 days

  • +17 more secondary outcomes

Study Arms (2)

Narcoleptic patients

OTHER
Other: Sleep and metabolism assessment

hypersomnic patients

OTHER
Other: Sleep and metabolism assessment

Interventions

Narcoleptic patientshypersomnic patients

Eligibility Criteria

Age6 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • NARCOLEPTIC PATIENTS
  • Girl or boy age\> 6 years \<18 years;
  • Narcoleptic: defined by the ICSD diagnostic criteria 2 (International Classification of Sleep Disorders)
  • Beginning of the troubles there more than 6 months
  • Parental consent and agreement of the child.
  • HYPERSOMNIC PATIENTS
  • Girl or boy age\> 6 years \<18 years;
  • Hypersomnic : defined by the ICSD diagnostic criteria 2 (International Classification of Sleep Disorders)
  • Beginning of the troubles there more than 6 months
  • Parental consent and agreement of the child.

You may not qualify if:

  • NARCOLEPTIC PATIENTS
  • Secondary Narcolepsy;
  • Narcolepsy already treated with psychostimulant or anticataplectic;
  • Restless legs;
  • Sleep apnea syndrome;
  • Obesity known outside narcolepsy cause;
  • Absence of parental consent.
  • HYPERSOMNIC PATIENTS
  • symptomatic or secondary hypersomnia;
  • Hypersomnia already treated psychostimulant or anticataplectic; Restless legs;
  • Sleep apnea syndrome;
  • Pathology neurological, psychiatric, endocrine or concurrent;
  • Lack of parental consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Service d'Exploration et pathologie du sommeil, Hôpital Femme Mère Enfant

Bron, 69677, France

Location

MeSH Terms

Conditions

Narcolepsy

Interventions

Sleep

Condition Hierarchy (Ancestors)

Disorders of Excessive SomnolenceSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Intervention Hierarchy (Ancestors)

Nervous System Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 3, 2016

First Posted

June 15, 2016

Study Start

December 20, 2013

Primary Completion

September 1, 2018

Study Completion

September 1, 2018

Last Updated

December 19, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations